Pregnant Texas woman says unborn baby should count as car passenger after receiving HOV ticket

Pregnant Texas woman says unborn baby should count as car passenger after receiving HOV ticket


Emilija Manevska | Moment | Getty Images

A pregnant Texas woman said her unborn baby should count as a second passenger in her vehicle after she received a ticket, citing Texas’ penal code in the wake of Roe v. Wade’s being overturned.

Brandy Bottone, 32, of Plano, was pulled over June 29 after she drove in an HOV lane, or high-occupancy vehicle land, NBC-Dallas Fort Worth reported. Bottone was stopped by the Dallas County Sheriff’s Department, which was looking for drivers violating the HOV lane rules.

The HOV lane requires drivers to have at least one passenger in their cars when they use the lane.

When a sheriff’s deputy told Bottone about the rule, she said she did, in fact, have a second occupant in her car — her unborn baby.

“I pointed to my stomach and said, ‘My baby girl is right here. She is a person,'” Bottone told The Dallas Morning News, which first reported the story.

The officer responded that the rule applies to “two people outside of the body.”

Bottone, who was 34 weeks pregnant at the time, told the officers that with the overturning of Roe v. Wade, her unborn child now was recognized as a living person. The U.S. Supreme Court overturned Roe v. Wade on June 24.

‘And then I said, ‘Well [I’m] not trying to throw a political mix here, but with everything going on, this counts as a baby,'” Bottone told NBC-Dallas-Fort Worth.

Bottone told The Morning News that the officer told her he didn’t “want to deal with this” and insisted that the law for HOV lanes required there to be “two persons outside of the body.”

Although the penal code in Texas recognizes a fetus as a person, it appears there’s no language in the state Transportation Department’s code that recognizes a fetus as a person or a passenger.

Representatives for sheriff’s department and the state Transportation Department didn’t immediately respond to requests for comment.

Deputies told Bottone that if she fought the ticket, it would likely be dismissed. She plans to fight the $215 ticket with the argument that her in-utero baby should count as another occupant of her vehicle.

“This has my blood boiling. How could this be fair? According to the new law, this is a life,” Bottone told The Morning News. “I know this may fall on deaf ears, but as a woman, this was shocking.”



Source

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 
Health

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual care company Omada Health on Thursday said it will start prescribing GLP-1s and other obesity drugs and helping patients manage those medications. Omada plans to expand the offerings under its weight management program as its membership grows […]

Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Health

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]

Read More
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 
Health

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 

Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, called eloralintide, helped patients […]

Read More